Neuropathic Pain Market Forecast: New research report available at Fast Market Research

New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research
 
April 17, 2011 - PRLog -- Introduction

At present, only six drugs are indicated for the treatment of neuropathic pain. In 2010, two significant events impacted the neuropathic pain market: the launch of Qutenza (8% capsaicin patch; NeurogesX/Astellas) in the US and EU; and the high-profile failure of ralfinamide (NW-1029; Newron) for the treatment of neuropathic low back pain.

Features and benefits

* In depth analysis of historic (2005-09) and future (2010-19) seven major market prescription sales dynamics.
* Includes neuropathic pain and country-specific sales forecasts for key brands, generics and pipeline drugs in the seven major markets to 2019.

Highlights

The neuropathic pain market is expected to achieve peak sales of $4.1bn over the forecast period (2010-19) across the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK).
In addition to existing brands expanding into new regions, Datamonitor forecasts a total of eight pipeline candidates to enter the neuropathic pain market over the forecast period (2010-19) across the seven major markets.
The broad label approval of Nucynta ER (extended-release tapentadol; Johnson & Johnson/Grunenthal) will drive market growth, while the launch of novel and topical agents will broaden treatment options.

Your key questions answered

* What will be the impact of major generic launches to the neuropathic pain market and what are the implications to prospective players?
* What are the most promising drug candidates in development for the potential treatment of neuropathic pain?
* What is the expected uptake of topical reformulations for neuropathic pain?
* What is the commercial potential of Qutenza (8% capsaicin patch; NeurogesX/Astellas) following its 2010 launch?


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/149245_neuropathic_pain_market...


Report Table of Contents:

OVERVIEW
Summary
OVERVIEW
This product contains forecasts for neuropathic pain drugs across the seven major markets from 2010 to 2019. It has been designed for delivery in an excel data pack format, but for more detail about this disease area please see the accompanying Pipeline and Commercial Insight: Neuropathic Pain Word document and PowerPoint executive presentation (HC00019-001).
The associated report and PowerPoint presentation can be found under Latest research in the Knowledge centre, through the search function or by contacting your sales representative.
Please select the data pack option from the download menu at the side of the page to access the model.
Introduction
Highlights
Features and benefits
Your key questions answered
Forecasting Methodology
The forecasting model:
General event information:
Event selection and quantification:
Event parameters:
Disclaimer

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment.  View more research from Datamonitor at http://www.fastmr.com/catalog/publishers.aspx?pubid=1002

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
End
Source: » Follow
Email:***@fastmr.com Email Verified
Zip:01267
Tags:Pain, Neuropathic, Treatment, Pipeline, 2010-19, Drugs, Drug, Neurogesxastellas, Qutenza, Powerpoint
Industry:Medical, Research, Biotech
Location:Massachusetts - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Fast Market Research News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share